These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 16465392

  • 21. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K, Trevino V, Falciani F, Stewart PM, Hewison M, Campbell MJ.
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery.
    Smith MJ, Culhane AC, Killeen S, Kelly MA, Wang JH, Cotter TG, Redmond HP.
    Ann Surg Oncol; 2008 Oct; 15(10):2954-64. PubMed ID: 18622646
    [Abstract] [Full Text] [Related]

  • 26. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 27. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
    Jung HH, Lee J, Kim JH, Ryu KJ, Kang SA, Park C, Sung K, Nam DH, Kang WK, Park K, Im YH.
    FEBS Lett; 2005 Jul 18; 579(18):3941-6. PubMed ID: 15996661
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
    Spurgers KB, Coombes KR, Meyn RE, Gold DL, Logothetis CJ, Johnson TJ, McDonnell TJ.
    Oncogene; 2004 Mar 04; 23(9):1712-23. PubMed ID: 14647426
    [Abstract] [Full Text] [Related]

  • 30. Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R.
    Beck MT, Peirce SK, Chen WY.
    Oncogene; 2002 Aug 01; 21(33):5047-55. PubMed ID: 12140755
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC, Jiang XP, Elliott RL, Head JF.
    Anticancer Res; 2001 Aug 01; 21(3B):1777-87. PubMed ID: 11497259
    [Abstract] [Full Text] [Related]

  • 32. Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy.
    Schulte JH, Schramm A, Pressel T, Klein-Hitpass L, Kremens B, Eils J, Havers W, Eggert A.
    Klin Padiatr; 2003 Aug 01; 215(6):298-302. PubMed ID: 14677092
    [Abstract] [Full Text] [Related]

  • 33. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT, Sarvilinna NS, Purmonen SR, Ylikomi TJ.
    Steroids; 2009 Aug 01; 74(4-5):404-9. PubMed ID: 19146866
    [Abstract] [Full Text] [Related]

  • 34. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.
    Capeáns C, Piñeiro A, Domínguez F, Loidi L, Buceta M, Carneiro C, Garcia-Caballero T, Sanchez-Salorio M.
    Exp Eye Res; 1998 May 01; 66(5):581-9. PubMed ID: 9628805
    [Abstract] [Full Text] [Related]

  • 35. Effects of emodin on gene expression profile in small cell lung cancer NCI-H446 cells.
    Fu ZY, Han JX, Huang HY.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1710-5. PubMed ID: 17935676
    [Abstract] [Full Text] [Related]

  • 36. Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil.
    Behera RK, Nayak R.
    Cancer Invest; 2009 Jun 05; 27(5):561-7. PubMed ID: 19219653
    [Abstract] [Full Text] [Related]

  • 37. Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.
    Dritschilo A, Huang CH, Rudin CM, Marshall J, Collins B, Dul JL, Zhang C, Kumar D, Gokhale PC, Ahmad A, Ahmad I, Sherman JW, Kasid UN.
    Clin Cancer Res; 2006 Feb 15; 12(4):1251-9. PubMed ID: 16489081
    [Abstract] [Full Text] [Related]

  • 38. Abrogation of c-Raf expression induces apoptosis in tumor cells.
    Lau QC, Brüsselbach S, Müller R.
    Oncogene; 1998 Apr 09; 16(14):1899-902. PubMed ID: 9583688
    [Abstract] [Full Text] [Related]

  • 39. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y, San-Marina S, Yang L, Khoury H, Minden MD.
    Breast Cancer Res; 2007 Apr 09; 9(4):R43. PubMed ID: 17634147
    [Abstract] [Full Text] [Related]

  • 40. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.
    Wisdom R, Huynh L, Hsia D, Kim S.
    Oncogene; 2005 Oct 27; 24(47):7043-54. PubMed ID: 16007133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.